PMID- 33513427 OWN - NLM STAT- MEDLINE DCOM- 20210910 LR - 20220503 IS - 1879-260X (Electronic) IS - 0925-4439 (Print) IS - 0925-4439 (Linking) VI - 1867 IP - 5 DP - 2021 May 1 TI - Deletion of Mcpip1 in Mcpip1(fl/fl)Alb(Cre) mice recapitulates the phenotype of human primary biliary cholangitis. PG - 166086 LID - S0925-4439(21)00019-3 [pii] LID - 10.1016/j.bbadis.2021.166086 [doi] AB - Primary biliary cholangitis (PBC) is an autoimmune disease characterized by progressive destruction of the intrahepatic bile ducts. The immunopathology of PBC involves excessive inflammation; therefore, negative regulators of inflammatory response, such as Monocyte Chemoattractant Protein-1-Induced Protein-1 (MCPIP1) may play important roles in the development of PBC. The aim of this work was to verify whether Mcpip1 expression protects against development of PBC. Genetic deletion of Zc3h12a was used to characterize the role of Mcpip1 in the pathogenesis of PBC in 6-52-week-old mice. We found that Mcpip1 deficiency in the liver (Mcpip1(fl/fl)Alb(Cre)) recapitulates most of the features of human PBC, in contrast to mice with Mcpip1 deficiency in myeloid cells (Mcpip1(fl/fl)LysM(Cre) mice), which present with robust myeloid cell-driven systemic inflammation. In Mcpip1(fl/fl)Alb(Cre) livers, intrahepatic bile ducts displayed proliferative changes with inflammatory infiltration, bile duct destruction, and fibrosis leading to cholestasis. In plasma, increased concentrations of IgG, IgM, and AMA autoantibodies (anti-PDC-E2) were detected. Interestingly, the phenotype of Mcpip1(fl/fl)Alb(Cre) mice was robust in 6-week-old, but milder in 12-24-week-old mice. Hepatic transcriptome analysis of 6-week-old and 24-week-old Mcpip1(fl/fl)Alb(Cre) mice showed 812 and 8 differentially expressed genes, respectively, compared with age-matched control mice, and revealed a distinct set of genes compared to those previously associated with development of PBC. In conclusion, Mcpip1(fl/fl)Alb(Cre) mice display early postnatal phenotype that recapitulates most of the features of human PBC. CI - Copyright (c) 2021 The Authors. Published by Elsevier B.V. All rights reserved. FAU - Kotlinowski, Jerzy AU - Kotlinowski J AD - Department of General Biochemistry, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Gronostajowa 7, 30-387 Krakow, Poland. Electronic address: j.kotlinowski@uj.edu.pl. FAU - Hutsch, Tomasz AU - Hutsch T AD - Department of Experimental Physiology and Pathophysiology, Laboratory of Centre for Preclinical Research, Medical University of Warsaw, Pawinskiego 3c, 02-106 Warsaw, Poland; Veterinary Diagnostic Laboratory ALAB bioscience, Stepinska 22/30, 00-739 Warszawa, Poland. FAU - Czyzynska-Cichon, Izabela AU - Czyzynska-Cichon I AD - Jagiellonian Centre for Experimental Therapeutics (JCET), Jagiellonian University, Bobrzynskiego 14, 30-348 Krakow, Poland. FAU - Wadowska, Marta AU - Wadowska M AD - Department of Microbiology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Gronostajowa 7, 30-387 Krakow, Poland. FAU - Pydyn, Natalia AU - Pydyn N AD - Department of General Biochemistry, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Gronostajowa 7, 30-387 Krakow, Poland. FAU - Jasztal, Agnieszka AU - Jasztal A AD - Jagiellonian Centre for Experimental Therapeutics (JCET), Jagiellonian University, Bobrzynskiego 14, 30-348 Krakow, Poland. FAU - Kij, Agnieszka AU - Kij A AD - Jagiellonian Centre for Experimental Therapeutics (JCET), Jagiellonian University, Bobrzynskiego 14, 30-348 Krakow, Poland. FAU - Dobosz, Ewelina AU - Dobosz E AD - Department of Microbiology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Gronostajowa 7, 30-387 Krakow, Poland. FAU - Lech, Maciej AU - Lech M AD - Department of Microbiology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Gronostajowa 7, 30-387 Krakow, Poland; Department of Medicine IV, LMU Hospital, Munich, Germany. FAU - Miekus, Katarzyna AU - Miekus K AD - Department of General Biochemistry, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Gronostajowa 7, 30-387 Krakow, Poland. FAU - Pospiech, Ewelina AU - Pospiech E AD - Malopolska Centre of Biotechnology, Jagiellonian University, Krakow, Poland. FAU - Fu, Mingui AU - Fu M AD - Department of Biomedical Science and Shock/Trauma Research Center, School of Medicine, University of Missouri-Kansas City, Kansas City, USA. FAU - Jura, Jolanta AU - Jura J AD - Department of General Biochemistry, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Gronostajowa 7, 30-387 Krakow, Poland. FAU - Koziel, Joanna AU - Koziel J AD - Department of Microbiology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Gronostajowa 7, 30-387 Krakow, Poland. FAU - Chlopicki, Stefan AU - Chlopicki S AD - Jagiellonian Centre for Experimental Therapeutics (JCET), Jagiellonian University, Bobrzynskiego 14, 30-348 Krakow, Poland; Chair of Pharmacology, Jagiellonian University Medical College, Grzegorzecka 16, 31-531 Krakow, Poland. LA - eng GR - R15 AI138116/AI/NIAID NIH HHS/United States PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20210126 PL - Netherlands TA - Biochim Biophys Acta Mol Basis Dis JT - Biochimica et biophysica acta. Molecular basis of disease JID - 101731730 RN - 0 (Autoantibodies) RN - 0 (Immunoglobulins) RN - EC 3.1.- (Ribonucleases) RN - EC 3.1.- (Zc3h12a protein, mouse) SB - IM MH - Animals MH - Autoantibodies/*immunology MH - Female MH - Immunoglobulins/*immunology MH - Inflammation/etiology/metabolism/*pathology MH - Liver Cirrhosis/etiology/metabolism/*pathology MH - Liver Cirrhosis, Biliary/etiology/metabolism/*pathology MH - Male MH - Mice MH - Mice, Inbred C57BL MH - Mice, Knockout MH - *Phenotype MH - Ribonucleases/*physiology PMC - PMC8938941 MID - NIHMS1779517 OTO - NOTNLM OT - Autoimmune disease OT - Inflammation OT - MCPIP1 OT - Primary biliary cholangitis OT - Regnase1 COIS- Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. EDAT- 2021/01/30 06:00 MHDA- 2021/09/11 06:00 PMCR- 2022/05/01 CRDT- 2021/01/29 20:06 PHST- 2020/09/04 00:00 [received] PHST- 2021/01/19 00:00 [revised] PHST- 2021/01/21 00:00 [accepted] PHST- 2021/01/30 06:00 [pubmed] PHST- 2021/09/11 06:00 [medline] PHST- 2021/01/29 20:06 [entrez] PHST- 2022/05/01 00:00 [pmc-release] AID - S0925-4439(21)00019-3 [pii] AID - 10.1016/j.bbadis.2021.166086 [doi] PST - ppublish SO - Biochim Biophys Acta Mol Basis Dis. 2021 May 1;1867(5):166086. doi: 10.1016/j.bbadis.2021.166086. Epub 2021 Jan 26.